Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death–Ligand 1 Interaction as Potential Anticancer AgentsBinbin Cheng, Jianjun Chen, Xiaoge Niu et al.|Journal of Medicinal Chemistry|2020Cited by 85